Viewing Study NCT01039233


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2026-03-03 @ 6:29 AM
Study NCT ID: NCT01039233
Status: COMPLETED
Last Update Posted: 2009-12-24
First Post: 2009-12-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions
Sponsor: Kremers Urban Development Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 50013
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Richard Larouche, M.D., Medical Director
Old Organization: sfbc Anapharm

Collaborators

Collaborators

Name Class View
None INDUSTRY View